当前位置： SCI文献检索 > ANNALS OF HEMATOLOGY期刊下所有文献 > 2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia.

2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia.

Abstract：

:2-Chlorodeoxyadenosine (2-CdA) is a purine analogue which has proved to be active in acute myeloid leukemia (AML), especially in children. In adults, results yielded by 2-CdA alone or with ara-C were less encouraging. Here we report on the efficacy of 2-CdA with or without daunorubicin (DNR) in 19 relapsing or refractory adult AML patients, with a median age of 57 years. 2-CdA was administered as a continuous infusion to all patients at a dose of 0.1 mg/kg per day for 7 days. For 14 patients, DNR was added at a dose of 50 mg/m2 per day on days 5, 6, and 7. Antileukemic activity was observed in all the patients, but no single complete remission was achieved. One patient had a long-lasting partial response (response rate=5%). The remaining patients died of progressive AML (n=7), uncontrollable infection with persistent disease (n=10), and cerebral hemorrhage (n=1). Median survival from start of 2-CdA therapy was 56 days. Long-lasting neutropenia and transfusion-dependent thrombopenia were encountered in all 16 evaluable patients. Grade 4 hepatic toxicity occurred in one patient. Other side effects included nausea in six, mucositis in three, and mental disturbances in three patients. Compared with 2-CdA alone, the addition of DNR to 2-CdA changed neither the response rate nor the toxicities. In conclusion, our data do not support the use of 2-CdA +/- DNR for relapsing or refractory adult AML patients, at least as used in the present regimen.

journal_name

Ann Hematol

journal_title

Annals of hematology

authors

Van Den Neste E,Martiat P,Mineur P,Delannoy A,Doyen C,Zenebergh A,Michaux JL,Ferrant A

doi

10.1007/s002770050355

subject

Has Abstract

pub_date

1998-01-01 00:00:00

pages

19-23

issue

1

eissn

0939-5555

issn

1432-0584

journal_volume

76

pub_type

临床试验,杂志文章,随机对照试验

相关文献

ANNALS OF HEMATOLOGY文献大全
  • Upfront autologous stem cell transplantation for untreated diffuse large B cell lymphoma patients in rituximab era: a systematic review and meta-analysis.

    abstract：:To assess the survival outcomes and adverse events (AEs) of high-intermediate- or high-risk patients with diffuse large B cell lymphoma (DLBCL) who underwent conventional chemotherapy plus rituximab with or without first-line autologous stem cell transplantation (ASCT). Related studies published on Medline, Embase, Co...

    journal_title：Annals of hematology

    pub_type： 杂志文章,meta分析

    doi：10.1007/s00277-020-04016-3

    authors： Ma SY,Tian XP,Cai J,Zhong GZ,Chen X,Huang HQ,Lin TY,Li ZM,Cai QQ

    更新日期：2020-06-01 00:00:00

  • Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells.

    abstract：:The present paper summarizes the results of the second German consensus meeting on immunogenetic donor search for allotransplantation of hematopoietic stem cells held in Essen in November 1999 under the auspices of the German Society for Immunogenetics (DGI) and the German Working Party for Blood and Marrow Transplant...

    journal_title：Annals of hematology

    pub_type： 共识发展会议,杂志文章,评审

    doi：10.1007/s00277-001-0384-9

    authors： Ottinger HD,Müller CR,Goldmann SF,Albert E,Arnold R,Beelen DW,Blasczyk R,Bunjes D,Casper J,Ebell W,Ehninger G,Eiermann T,Einsele H,Fauser A,Ferencik S,Finke J,Hertenstein B,Heyll A,Klingebiel T,Knipper A,Kremens B

    更新日期：2001-12-01 00:00:00

  • An unusual case of leukemic non-Hodgkin's lymphoma with blastic transformation.

    abstract：:We report on a patient who was diagnosed as having B-cell chronic lymphocytic leukemia (CLL) with atypical morphology. Flow cytometry disclosed CD5, CD19, and CD23 positivity, an immunophenotype seen mostly in B-CLL. Histology of the spleen and bone marrow suggested a diagnosis of small lymphocytic lymphoma. Upon blas...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s002770050582

    authors： Späth-Schwalbe E,Flath B,Kaufmann O,Thiel G,Brinckmann R,Dietel M,Possinger K

    更新日期：2000-04-01 00:00:00

  • Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study.

    abstract：:Ixazomib, the first oral proteasome inhibitor (PI), has been approved for the treatment of relapsed refractory multiple myeloma (RRMM) in combination with lenalidomide and dexamethasone, based on the TOURMALINE-MM1 phase 3 trial, which demonstrated the efficacy and safety of this all-oral triplet, compared with lenali...

    journal_title：Annals of hematology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s00277-020-03985-9

    authors： Cohen YC,Magen H,Lavi N,Gatt ME,Chubar E,Horowitz N,Kreiniz N,Tadmor T,Trestman S,Vitkon R,Rouvio O,Shvetz O,Shaulov A,Ziv-Baran T,Avivi I

    更新日期：2020-06-01 00:00:00

  • A review of the European LeukemiaNet recommendations for the management of CML.

    abstract：:Several guidelines and recommendations on the management of chronic myeloid leukemia (CML) have been prepared by several scientific societies. The European LeukemiaNet (ELN) appointed a panel of experts who submitted their recommendations to peer-reviewed scientific journals in 2006, 2009, and 2013. Here, we make a cr...

    journal_title：Annals of hematology

    pub_type： 杂志文章,评审

    doi：10.1007/s00277-015-2322-2

    authors： Baccarani M,Castagnetti F,Gugliotta G,Rosti G

    更新日期：2015-04-01 00:00:00

  • Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis.

    abstract：:A retrospective study of 120 patients with the clinically and histologically established diagnosis of idiopathic (primary) myelofibrosis (IMF) was performed to determine prognostic factors of predictive value, including parameters characterizing the dynamics of hematopoietic cell kinetics. In contrast to previous stud...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s002770050474

    authors： Kvasnicka HM,Thiele J,Regn C,Zankovich R,Diehl V,Fischer R

    更新日期：1999-02-01 00:00:00

  • Long-term outcome of follicular low-grade lymphoma. A report of 91 patients.

    abstract：:We retrospectively analyzed overall survival and survival after progression in 91 patients with low-grade follicular lymphoma (LGFL). Histological subtype was B in 75 patients and C in 16 patients. Twelve patients with localized disease received involved-field radiotherapy; seven patients without bulky disease had no ...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/BF01695972

    authors： Morel P,Dupriez B,Plantier-Colcher I,Gosselin B,Declercq C,Pollet JP,Bauters F

    更新日期：1993-06-01 00:00:00

  • In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity.

    abstract：:In vivo, growth factors are currently investigated for their capacity to trigger leukemic stem cells into cycle and thus overcome kinetic drug resistance. In this study, the susceptibility of leukemic clonogenic cells to individual growth factors was related to cytosine-arabinoside (Ara-C) sensitivity. The effects of ...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/BF01737421

    authors： Van der Lely N,De Witte T,Wessels J,Raymakers R,Muus P,Preijers F

    更新日期：1994-05-01 00:00:00

  • Correlation study between osteoporosis and hematopoiesis in the context of adjuvant chemotherapy for breast cancer.

    abstract：:This retrospective study attempts to establish if a correlation exists between osteoporosis and hematopoiesis before and after adjuvant chemotherapy in the context of non-metastatic breast cancer. Osteoporosis is interpreted both as a direct marker of osteoblastic decline and as an indirect marker of increased bone ma...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-017-3184-6

    authors： Schyrr F,Wolfer A,Pasquier J,Nicoulaz AL,Lamy O,Naveiras O

    更新日期：2018-02-01 00:00:00

  • Neutralization of stem cell factor in vitro and in vivo: dose-dependent inhibition of stromal cells and induction of granulocyte/monocyte differentiation.

    abstract：:Stem cell factor (SCF), also termed mast cell growth factor or c-kit ligand, plays a central role in the regulation of hematopoiesis and maintenance of viability of hematopoietic cells. We used a new murine monoclonal antibody (MAb) specific for canine SCF to further dissect the role of SCF in vitro and in vivo. This ...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s002770050168

    authors： Huss R,Hong DS,Beckham C,Storb R,Broudy VC,Deeg HJ

    更新日期：1996-04-01 00:00:00

  • Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.

    abstract：:Mixed phenotype acute leukemia (MPAL) is a rare type of leukemia with a limited number of studies conducted to characterize its clinical spectrum and most importantly the best treatment modality. MPAL blasts show more than one phenotype either myeloid/monocytic with T- or B-lymphoid or extremely rare triple lineage as...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-020-04354-2

    authors： Rasekh EO,Osman R,Ibraheem D,Madney Y,Radwan E,Gameel A,Abdelhafiz A,Kamel A,Elfishawi S

    更新日期：2020-11-23 00:00:00

  • Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.

    abstract：:Defects in central and peripheral tolerance are thought to contribute to life-threatening graft-versus-host disease (GvHD), a severe complication following allogeneic stem cell transplantation (SCT). Recent investigations have demonstrated regulatory T cells (Tregs) to suppress allogeneic immune reactions. Therefore, ...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-010-1068-0

    authors： Ukena SN,Grosse J,Mischak-Weissinger E,Buchholz S,Stadler M,Ganser A,Franzke A

    更新日期：2011-02-01 00:00:00

  • Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.

    abstract：:The practical usefulness of Helicobacter pylori eradication for immune thrombocytopenia (ITP) patients is still controversial. However, some ITP patients respond to H. pylori eradication. We conducted a multi-center, open label, prospective phase II study to define the efficacy and toxicities of H. pylori eradication ...

    journal_title：Annals of hematology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s00277-014-2268-9

    authors： Kim H,Lee WS,Lee KH,Bae SH,Kim MK,Joo YD,Zang DY,Jo JC,Lee SM,Lee JH,Lee JH,Kim DY,Ryoo HM,Hyun MS,Kim HJ,CoOperative Study Group A for Hematology (COSAH).

    更新日期：2015-05-01 00:00:00

  • No evidence for neoantigens in human plasma after photochemical virus inactivation.

    abstract：:Photodynamic virus inactivation of human fresh plasma mediated by visible light in the presence of the phenothiazine dyes methylene blue or toluidine blue was investigated to determine whether it influences functional, structural, and immunological properties of plasma proteins. The activities of the coagulation facto...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/BF01703949

    authors： Mohr H,Knüver-Hopf J,Lambrecht B,Scheidecker H,Schmitt H

    更新日期：1992-11-01 00:00:00

  • Biotherapy of chronic myelogenous leukemia.

    abstract：:The aim of this review is to summarize the current knowledge on the clinical results of biotherapy of chronic myelogenous leukemia (CML) and potential mechanisms of the antitumor action of interferon alpha. IFN alpha treatment induces hematologic and cytogenetic remissions in patients with chronic phase CML. In additi...

    journal_title：Annals of hematology

    pub_type： 杂志文章,评审

    doi：10.1007/BF01682030

    authors： Aulitzky WE,Peschel C,Schneller F,Huber C

    更新日期：1995-03-01 00:00:00

  • Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study.

    abstract：:Post-transplantation cyclophosphamide (PTCy) demonstrated effectiveness to prevent GVHD after haploidentical hematopoietic cell transplantation (HCT). Reducing toxicities with a maximized efficacy is still challenging in HCT. In this retrospective study, we analyzed the safety and efficacy of transplantation from a 1-...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-019-03673-3

    authors： Soltermann Y,Heim D,Medinger M,Baldomero H,Halter JP,Gerull S,Arranto C,Passweg JR,Kleber M

    更新日期：2019-06-01 00:00:00

  • Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

    abstract：:The Infectious Diseases Working Party of the German Society of Haematology and Oncology presents their guidelines for the treatment of fungal infections in patients with hematological and oncological malignancies. These guidelines are evidence-based, considering study results, case reports and expert opinions, using t...

    journal_title：Annals of hematology

    pub_type： 指南,杂志文章,实务指引

    doi：10.1007/s00277-003-0767-1

    authors： Böhme A,Ruhnke M,Buchheidt D,Karthaus M,Einsele H,Guth S,Heussel G,Heussel CP,Junghanss C,Kern WK,Kubin T,Maschmeyer G,Sezer O,Silling G,Südhoff T,Szelényi Dagger H,Ullmann AJ,Infectious Diseases Working Party (AGIHO) o

    更新日期：2003-10-01 00:00:00

  • Does mRNA level of microsomal carnitine palmitoyltransferase predict yield of peripheral blood stem cell apheresis?

    abstract：:Transplantation of autologous hematopoietic stem cells is a well established therapeutic procedure. Despite advances in efficacy of the stem cell mobilization and apheresis process until now a predictive factor for the expected stem cell yield before initiation of mobilization therapy could not be identified. The main...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-005-0074-0

    authors： Fillitz M,Karlic H,Tüchler H,Zeibig J,Spiegel W,Wihlidal P,Varga F,Pittermann E,Pfeilstöcker M

    更新日期：2006-06-01 00:00:00

  • Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.

    abstract：:In this retrospective study, we evaluated the clinical features and the effects of various treatment modalities on the clinical course in patients diagnosed with idiopathic thrombocytopenic purpura (ITP) at our center between 1984-2000. We retrospectively examined the medical records of 321 (229 females, 92 males) ITP...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-002-0488-x

    authors： Pamuk GE,Pamuk ON,Başlar Z,Ongören S,Soysal T,Ferhanoğlu B,Aydin Y,Ulkü B,Aktuğlu G,Akman N

    更新日期：2002-08-01 00:00:00

  • Pregnancy in patients with thalassemia major: a cohort study and conclusions for an adequate care management approach.

    abstract：:An improvement in quality of life and survival occurred among thalassemia major (TM) patients: pregnancy in such patients has become a reality. Safe pregnancy and delivery require efforts to ensure the best outcomes. Between 2007 and 2016, 30 TM patients had 37 pregnancies. We analyzed the hematological parameters bef...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-017-2979-9

    authors： Cassinerio E,Baldini IM,Alameddine RS,Marcon A,Borroni R,Ossola W,Taher A,Cappellini MD

    更新日期：2017-06-01 00:00:00

  • Clinical applications of new antithrombotic agents.

    abstract：:The clinical targets for which new generations of antithrombotics have been or are currently under clinical development are those associated with a high risk for thromboembolism, (a) patients undergoing general, orthopedic, major abdominal, and cancer surgery, to prevent venous thromboembolism; (b) patients with deep-...

    journal_title：Annals of hematology

    pub_type： 杂志文章,评审

    doi：10.1007/s002770050158

    authors： Beijering RJ,ten Cate H,ten Cate JW

    更新日期：1996-04-01 00:00:00

  • The effect of pre-eclampsia on complete blood count, platelet count and mean platelet volume.

    abstract：:Pre-eclampsia is a condition observed during pregnancy and threatens the life of both mother and foetus. There are studies, which suggest platelets play a major role in the pathogenesis of pre-eclampsia. The aim of this study is to compare the complete blood count (CBC) parameters, especially platelet count and mean p...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-006-0091-7

    authors： Ceyhan T,Beyan C,Başer I,Kaptan K,Güngör S,Ifran A

    更新日期：2006-05-01 00:00:00

  • Overexpressed WT1 exhibits a specific immunophenotype in intermediate and poor cytogenetic risk acute myeloid leukemia.

    abstract：:Many studies have confirmed that overexpressed WT1 exists in leukemic cells, especially in AML. However, the immunophenotypic features of this sort of leukemic cells remain to be unclarified. We retrospectively analyzed the immunophenotype of 283 newly diagnosed AML patients with intermediated and poor cytogenetic ris...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-019-03808-6

    authors： Wang XR,Chang Y,Yuan XY,Wang YZ,Qin YZ,Ruan GR,Lai YY,Liu YR

    更新日期：2020-02-01 00:00:00

  • Historical review. The light and shadow of Paul Kaznelson: his life and contribution to hematology.

    abstract：:Paul Kaznelson is credited with describing the first case of pure red cell aplasia. He was also known for his contribution to the discovery of the therapeutic role of splenectomy in idiopathic thrombocytopenic purpura. Most of his academic works appeared in 1910s and 1920s, when he used to work in Karl-Ferdinand Unive...

    journal_title：Annals of hematology

    pub_type： 传,历史文章,杂志文章

    doi：10.1007/s00277-008-0553-1

    authors： Yoshida Y

    更新日期：2008-11-01 00:00:00

  • Headache prevalence following recovery from TTP and aHUS.

    abstract：:Thrombotic thrombocytopenia purpura (TTP) and atypical hemolytic uremic syndromes (aHUS) are distinct clinical disorders characterized by hemolytic anemia, thrombocytopenia, microthrombi, and end organ damage. TTP is characterized by a low ADAMTS13 activity level at diagnosis of <10 % ADAMTS13 activity, while aHUS is ...

    journal_title：Annals of hematology

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00277-015-2411-2

    authors： Saultz JN,Wu HM,Cataland S

    更新日期：2015-09-01 00:00:00

  • Treatment of primary mediastinal large B cell lymphoma with an alternating chemotherapy regimen based on high-dose methotrexate.

    abstract：:Primary mediastinal large B cell lymphomas (MLCL) differ from other diffuse large cell lymphomas, leading to a description as a separate entity in the current World Health Organization classification. Dose intensification improves long-term results, but no standard therapy has been established so far. We investigated ...

    journal_title：Annals of hematology

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1007/s00277-008-0625-2

    authors： Fietz T,Knauf WU,Hänel M,Franke A,Freund M,Thiel E,East German Study Group on Hematology and Oncology-OSHO.

    更新日期：2009-05-01 00:00:00

  • Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant.

    abstract：:Standard conditioning for allogeneic bone marrow transplantation induces high transplant-related mortality (TRM) in patients with a poor performance status. Less intensive regimens have been tested to reduce the TRM; our purpose was to evaluate the feasibility and tolerability of a new combination: thiotepa and fludar...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s002770100344

    authors： Alessandrino EP,Bernasconi P,Colombo AA,Caldera D,Bonfichi M,Pagnucco G,Malcovati L,Varettoni M,Lazzarino M,Bernasconi C

    更新日期：2001-09-01 00:00:00

  • The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients.

    abstract：:Elevation of echocardiography-determined tricuspid regurgitant jet velocity (TRV) predicts high systolic pulmonary artery pressure. The present study tested the hypotheses that elevated tricuspid regurgitant jet velocity is associated with both hemolysis and hypoxia and abnormal 6-min walk test (6MWT) results. This st...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-014-2030-3

    authors： Agha H,El Tagui M,El Ghamrawy M,Abdel Hady M

    更新日期：2014-07-01 00:00:00

  • Meningeal and cerebral involvement in multiple myeloma patients.

    abstract：:Cerebral involvement is an unusual complication in multiple myeloma: herein four patients who presented myelomatous meningitis with multiple intraparenchymal lesions or a localized cerebral plasmacytoma are described. Two of these patients relapsed with meningeal involvement and a very limited disease outside the cent...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-001-0387-6

    authors： Patriarca F,Zaja F,Silvestri F,Sperotto A,Scalise A,Gigli G,Fanin R

    更新日期：2001-12-01 00:00:00

  • Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation.

    abstract：:Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative treatment option for myelofibrosis (MF) despite the emergence of novel targeted therapies. To reduce graft rejection and graft-versus-host disease (GvHD), current allo-HCT protocols often include in vivo T lymphocyte depletion using pol...

    journal_title：Annals of hematology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s00277-016-2758-z

    authors： Ecsedi M,Schmohl J,Zeiser R,Drexler B,Halter J,Medinger M,Duyster J,Kanz L,Passweg J,Finke J,Bethge W,Lengerke C

    更新日期：2016-10-01 00:00:00